These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 19732972)
1. Multiple switches in G protein-coupled receptor activation. Ahuja S; Smith SO Trends Pharmacol Sci; 2009 Sep; 30(9):494-502. PubMed ID: 19732972 [TBL] [Abstract][Full Text] [Related]
2. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors. Bhattacharya S; Hall SE; Vaidehi N J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482 [TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Park JH; Scheerer P; Hofmann KP; Choe HW; Ernst OP Nature; 2008 Jul; 454(7201):183-7. PubMed ID: 18563085 [TBL] [Abstract][Full Text] [Related]
4. Molecular basis of inverse agonism in a G protein-coupled receptor. Vilardaga JP; Steinmeyer R; Harms GS; Lohse MJ Nat Chem Biol; 2005 Jun; 1(1):25-8. PubMed ID: 16407989 [TBL] [Abstract][Full Text] [Related]
5. Structure of rhodopsin and the metarhodopsin I photointermediate. Schertler GF Curr Opin Struct Biol; 2005 Aug; 15(4):408-15. PubMed ID: 16043340 [TBL] [Abstract][Full Text] [Related]
6. X-ray crystallographic studies for ligand-protein interaction changes in rhodopsin. Okada T Biochem Soc Trans; 2004 Nov; 32(Pt 5):738-41. PubMed ID: 15494002 [TBL] [Abstract][Full Text] [Related]
7. Transmembrane signaling by GPCRs: insight from rhodopsin and opsin structures. Choe HW; Park JH; Kim YJ; Ernst OP Neuropharmacology; 2011 Jan; 60(1):52-7. PubMed ID: 20708633 [TBL] [Abstract][Full Text] [Related]
8. Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design. Gloriam DE; Foord SM; Blaney FE; Garland SL J Med Chem; 2009 Jul; 52(14):4429-42. PubMed ID: 19537715 [TBL] [Abstract][Full Text] [Related]
9. Location and nature of the residues important for ligand recognition in G-protein coupled receptors. Bywater RP J Mol Recognit; 2005; 18(1):60-72. PubMed ID: 15386622 [TBL] [Abstract][Full Text] [Related]
10. Predisposition of the dark state of rhodopsin to functional changes in structure. Isin B; Rader AJ; Dhiman HK; Klein-Seetharaman J; Bahar I Proteins; 2006 Dec; 65(4):970-83. PubMed ID: 17009319 [TBL] [Abstract][Full Text] [Related]
11. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery. Huber T; Menon S; Sakmar TP Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775 [TBL] [Abstract][Full Text] [Related]
13. The fourth intracellular domain of G-protein coupling receptors: helicity, basicity and similarity to opsins. Parker MS; Parker SL Amino Acids; 2010 Jan; 38(1):1-13. PubMed ID: 19565325 [TBL] [Abstract][Full Text] [Related]
14. Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation. Peeters MC; van Westen GJ; Li Q; IJzerman AP Trends Pharmacol Sci; 2011 Jan; 32(1):35-42. PubMed ID: 21075459 [TBL] [Abstract][Full Text] [Related]
16. The all-trans-15-syn-retinal chromophore of metarhodopsin III is a partial agonist and not an inverse agonist. Mahalingam M; Vogel R Biochemistry; 2006 Dec; 45(51):15624-32. PubMed ID: 17176084 [TBL] [Abstract][Full Text] [Related]
17. Improvements in G protein-coupled receptor purification yield light stable rhodopsin crystals. Salom D; Le Trong I; Pohl E; Ballesteros JA; Stenkamp RE; Palczewski K; Lodowski DT J Struct Biol; 2006 Dec; 156(3):497-504. PubMed ID: 16837211 [TBL] [Abstract][Full Text] [Related]
18. Inverse agonists: tools to reveal ligand-specific conformations of G protein-coupled receptors. Prather PL Sci STKE; 2004 Jan; 2004(215):pe1. PubMed ID: 14722344 [TBL] [Abstract][Full Text] [Related]